Answers are grounded in this paper and cite their sources.
Cohort study shows acne is common in adolescents with inflammatory bowel disease on JAKi, highlighting treatment needs.
In this single-center cohort study, acne was a common adverse event among pediatric patients taking JAKi for IBD. Referral and treatment patterns in our cohort varied greatly, which demonstrates the need for a multidisciplinary approach and larger prospective studies to discern the prevalence, characteristics, and treatment response of JAKi-induced acne to inform risks and benefits.
No takes yet. Share an insight, caveat, or question.
Barclay et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: